Treatment of Choroidal Metastasis from Epidermal Growth Factor Mutant Non-Small Cell Lung Cancer with First-line Osimertinib Therapy.
Anderson N VuUrmi V MehtaPaul IsraelsenSai-Hong Ignatius OuAndrew W BrownePublished in: Journal of ophthalmic & vision research (2022)
After the initiation of osimertinib, ophthalmic and computed tomography imaging highlighted the regression of the ocular metastatic disease and primary malignancy, respectively.Osimertinib is an effective first-line treatment of EGFR+ NSCLC and corresponding metastatic sites. Additionally, ophthalmic imaging can be used to monitor general response to chemotherapy agents when ocular metastasis is identified.
Keyphrases
- small cell lung cancer
- growth factor
- advanced non small cell lung cancer
- epidermal growth factor receptor
- computed tomography
- high resolution
- brain metastases
- squamous cell carcinoma
- optic nerve
- optical coherence tomography
- positron emission tomography
- magnetic resonance imaging
- tyrosine kinase
- locally advanced
- mass spectrometry
- fluorescence imaging
- magnetic resonance
- bone marrow
- cell therapy
- wound healing
- replacement therapy
- smoking cessation